VIRTUAL PANEL SERIESNEW FOR 2020
The buzz around the potential of Precision Medicine continues as new technologies, more powerful computing and our ability to store, share and interpret Big Data increases. Yet with differing healthcare systems, regulatory obstacles, reimbursement challenges, ethical concerns and many more issues, there are a multitude of hurdles to overcome before we will see ubiquitous precision medicine. Of course, the ultimate goal is to achieve clinical implementation of a personalised medicine approach.
It will take the combined efforts of healthcare providers, research, industry, Government and patient groups, as well as harnessing the undoubted potential of technology, to realise the potential of precision medicine. By bringing these groups together we hope to help break down these barriers
Our aim is to facilitate global collaboration in precision medicine – what many see as the key to unlocking the promise of a personalised approach to healthcare. We do this through our events, social media, newsletters and our website. Join us and let’s make a difference together.
To learn more about our upcoming events please click the links or view them all here. For our latest interviews, guest blogs, news and more just scroll down.
“…a great event which surpassed my expectations; one of the best conferences I have been to for yearsVP and Head, Genome Sciences & Technologies, Worldwide R&D Pfizer Inc.
Prof Kjetil Tasken speaking about the cost of CAR T-cells therapy and inequalities in cancer treatment
Prof Kjetil Tasken speaks about CAR T-cells therapy and inequalities in cancer treatment...Features
Prof. Magnus Essand, of Uppsala University, speaks about oncolytic viruses and their potential as a treatment option
Prof. Magnus Essand, of Uppsala University, joined us for our Virtual Panel Discussion on...Features
Dr. Capucine Baldini, speaks about how Gustave Roussy dealt with the first and second waves of the pandemic
Dr. Capucine Baldini, of Gustave Roussy, speaks about how Gustave Roussy dealt with the first...Features
Eibhlin Mulroe, of Cancer Trials Ireland, speaks about the re-opening of hospital sites for clinical trials
Eibhlin Mulroe spoke to PMF about the difficulties of performing clinical trials in hospitals...Features